22 April 2023>: Clinical Research
Measurement of Serum Ultra-Sensitive Thyroid-Stimulating Hormone Levels to Determine the Risk for Recurrence of Atrial Fibrillation Following Catheter Ablation in 575 Patients from a Single Center
Zhizhao Li 1ABCDEFG* , Xiao-Xia Liu 2AF , Qiong Huang 3F , Yu-Qing Song 1F* , Xue-Yuan Guo 2AF , Chang-Sheng Ma 2A*DOI: 10.12659/MSM.937958
Med Sci Monit 2023; 29:e937958
Table 6 uTsh and risk for redo of AF.
All subject | Women | Men | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
BE | SE | HR (95% CI) | P value | BE | SE | HR (95% CI) | P value | BE | SE | HR (95% CI) | P value | |
uTSH (per 1 miu/L increase) | 0.05 | 0.03 | 1.05 (0.99–1.12) | 0.10 | 0.04 | 0.04 | 1.03 (0.74–2.06) | 0.28 | 0.07 | 0.06 | 1.03 (0.74–2.06) | 0.23 |
uTSH (per 1 miu/L increase) | 0.07 | 0.05 | 1.08 (0.73–1.60) | 0.70 | 0.02 | 0.05 | 1.02 (0.92–1.12) | 0.75 | 0.03 | 0.08 | 1.03 (0.87–1.21) | 0.75 |
* Statistically significant value ( was adjusted for sex and age. was adjusted for all the relevant factors. |